Sec. 308. REAUTHORIZATION OF REPORTING REQUIREMENTS RELATED TO PENDING GENERIC DRUG APPLICATIONS AND PRIORITY REVIEW APPLICATIONS
47 words·~1 min read·
/statute-compilations/comps-17123/sec-308A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
## SEC. 308 REAUTHORIZATION OF REPORTING REQUIREMENTS RELATED TO PENDING GENERIC DRUG APPLICATIONS AND PRIORITY REVIEW APPLICATIONS Section 807 of the FDA Reauthorization Act of 2017 (Public Law 115-52) is amended, in the matter preceding paragraph (1), by striking “December 16, 2022” and inserting “December 23, 2022”.
Connectionstraces to 1
Traces to 1 document
public-private-law
Citation graph
cites case law
Sec. 308
REAUTHORIZATION OF REPORTING REQUIREMENTS RELATED TO PENDING GENERIC DRUG APPLICATIONS AND PRIORITY REVIEW APPLICATIONS
Cites 1Cited by 0 across 0 sources